Testosterone replacement and prostate cancer

This article is intended as a review of the available clinical data outlining the risks and benefits of testosterone (androgen) replacement therapy, specifically addressing the issue of the relationship between exogenous androgen administration and prostate cancer risk. There is controversy over whe...

Full description

Bibliographic Details
Main Authors: Ranjith Ramasamy, Erik S Fisher, Peter N Schlegel
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2012-01-01
Series:Indian Journal of Urology
Subjects:
Online Access:http://www.indianjurol.com/article.asp?issn=0970-1591;year=2012;volume=28;issue=2;spage=123;epage=128;aulast=Ramasamy
_version_ 1798043399470710784
author Ranjith Ramasamy
Erik S Fisher
Peter N Schlegel
author_facet Ranjith Ramasamy
Erik S Fisher
Peter N Schlegel
author_sort Ranjith Ramasamy
collection DOAJ
description This article is intended as a review of the available clinical data outlining the risks and benefits of testosterone (androgen) replacement therapy, specifically addressing the issue of the relationship between exogenous androgen administration and prostate cancer risk. There is controversy over whether androgen replacement is a risk factor for incident prostate cancer. Our review of current clinical information revealed that to date, no study or review has definitively shown that androgen replacement therapy is an independent risk factor for development of prostate cancer. Androgen administration seems to be beneficial in decreasing fatal cardiovascular events, body fat mass, and insulin resistance. Overall, the current clinical data seems to suggest that androgen replacement is an appropriate therapeutic option for men with symptomatic hypogonadism provided that patients continue to receive regular prostate screenings.
first_indexed 2024-04-11T22:48:32Z
format Article
id doaj.art-ec58de5f411f4b7ea7e4acaa413ec076
institution Directory Open Access Journal
issn 0970-1591
1998-3824
language English
last_indexed 2024-04-11T22:48:32Z
publishDate 2012-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Urology
spelling doaj.art-ec58de5f411f4b7ea7e4acaa413ec0762022-12-22T03:58:41ZengWolters Kluwer Medknow PublicationsIndian Journal of Urology0970-15911998-38242012-01-0128212312810.4103/0970-1591.98449Testosterone replacement and prostate cancerRanjith RamasamyErik S FisherPeter N SchlegelThis article is intended as a review of the available clinical data outlining the risks and benefits of testosterone (androgen) replacement therapy, specifically addressing the issue of the relationship between exogenous androgen administration and prostate cancer risk. There is controversy over whether androgen replacement is a risk factor for incident prostate cancer. Our review of current clinical information revealed that to date, no study or review has definitively shown that androgen replacement therapy is an independent risk factor for development of prostate cancer. Androgen administration seems to be beneficial in decreasing fatal cardiovascular events, body fat mass, and insulin resistance. Overall, the current clinical data seems to suggest that androgen replacement is an appropriate therapeutic option for men with symptomatic hypogonadism provided that patients continue to receive regular prostate screenings.http://www.indianjurol.com/article.asp?issn=0970-1591;year=2012;volume=28;issue=2;spage=123;epage=128;aulast=RamasamyAndrogen replacementhypogonadismprostate
spellingShingle Ranjith Ramasamy
Erik S Fisher
Peter N Schlegel
Testosterone replacement and prostate cancer
Indian Journal of Urology
Androgen replacement
hypogonadism
prostate
title Testosterone replacement and prostate cancer
title_full Testosterone replacement and prostate cancer
title_fullStr Testosterone replacement and prostate cancer
title_full_unstemmed Testosterone replacement and prostate cancer
title_short Testosterone replacement and prostate cancer
title_sort testosterone replacement and prostate cancer
topic Androgen replacement
hypogonadism
prostate
url http://www.indianjurol.com/article.asp?issn=0970-1591;year=2012;volume=28;issue=2;spage=123;epage=128;aulast=Ramasamy
work_keys_str_mv AT ranjithramasamy testosteronereplacementandprostatecancer
AT eriksfisher testosteronereplacementandprostatecancer
AT peternschlegel testosteronereplacementandprostatecancer